-
1
-
-
34547676822
-
Allergenic pollen and pollen allergy in Europe
-
D'Amato G, Cecchi L, Bonini S, Nunes C, Annesi-Maesano I, Behrendt H et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007;62:976-990.
-
(2007)
Allergy
, vol.62
, pp. 976-990
-
-
D'Amato, G.1
Cecchi, L.2
Bonini, S.3
Nunes, C.4
Annesi-Maesano, I.5
Behrendt, H.6
-
3
-
-
40549093007
-
Allergic rhinitis and its impact on asthma (ARIA) 2008 update
-
in collaboration with the World Health Organization, GA(2)LEN and Aller-Gen
-
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and Aller-Gen). Allergy 2008;63(Suppl. 86):8-160.
-
(2008)
Allergy
, vol.63
, pp. 8-160
-
-
Bousquet, J.1
Khaltaev, N.2
Cruz, A.A.3
Denburg, J.4
Fokkens, W.J.5
Togias, A.6
-
4
-
-
50249230114
-
Prophylactic inoculations against hay fever
-
Noon L. Prophylactic inoculations against hay fever. Lancet 1911;1:1572-1573.
-
(1911)
Lancet
, vol.1
, pp. 1572-1573
-
-
Noon, L.1
-
5
-
-
0031817107
-
WHO position paper: Allergen immunotherapy: Therapeutic vaccines for allergic diseases
-
Bousquet J, Lockey RF, Malling HJ. WHO position paper: allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53:1-42.
-
(1998)
Allergy
, vol.53
, pp. 1-42
-
-
Bousquet, J.1
Lockey, R.F.2
Malling, H.J.3
-
6
-
-
84863970198
-
Subcutaneous allergen immunotherapy for allergic disease: Examining efficacy, safety and cost-effectiveness of current and novel formulations
-
Cox L, Calderon M, Pfaar O. Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations. Immunotherapy 2012;6:1-16.
-
(2012)
Immunotherapy
, vol.6
, pp. 1-16
-
-
Cox, L.1
Calderon, M.2
Pfaar, O.3
-
7
-
-
58149460764
-
Adverse effects and fatalities associated with subcutaneous allergen immunotherapy
-
Bukantz SC, Bagg AS, Lockey RF. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy. Clin Allergy Immunol 2008;21:455-468.
-
(2008)
Clin Allergy Immunol
, vol.21
, pp. 455-468
-
-
Bukantz, S.C.1
Bagg, A.S.2
Lockey, R.F.3
-
9
-
-
0014988001
-
Preparation and properties of allergoids, derived from native pollen allergens by mild formalin treatment
-
Marsh DG. Preparation and properties of allergoids, derived from native pollen allergens by mild formalin treatment. Int Arch Allergy Appl Immunol 1971;41:199-215.
-
(1971)
Int Arch Allergy Appl Immunol
, vol.41
, pp. 199-215
-
-
Marsh, D.G.1
-
10
-
-
33747640551
-
Accelerated immunotherapy schedules: Review of efficacy and safety
-
Cox L. Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol 2006;97:126-137.
-
(2006)
Ann Allergy Asthma Immunol
, vol.97
, pp. 126-137
-
-
Cox, L.1
-
12
-
-
85086684180
-
Cluster-Immuntherapie bei allergischer Rhinokonjunktivitis
-
Hansen I, Hormann K, Stuck BA, Schneider-Gene S, Mösges R, Klimek L. Cluster-Immuntherapie bei allergischer Rhinokonjunktivitis. Allergologie 2002;25:549-556.
-
(2002)
Allergologie
, vol.25
, pp. 549-556
-
-
Hansen, I.1
Hormann, K.2
Stuck, B.A.3
Schneider-Gene, S.4
Mösges, R.5
Klimek, L.6
-
13
-
-
15044341738
-
Prospective safety study of immunotherapy administered in a cluster schedule
-
Serrano P, Algorta J, Martinez A, Gonzalez-Quevedo T, Velazquez E, Diaz M. Prospective safety study of immunotherapy administered in a cluster schedule. J Investig Allergol Clin Immunol 2004;14:312-319.
-
(2004)
J Investig Allergol Clin Immunol
, vol.14
, pp. 312-319
-
-
Serrano, P.1
Algorta, J.2
Martinez, A.3
Gonzalez-Quevedo, T.4
Velazquez, E.5
Diaz, M.6
-
14
-
-
21344467468
-
Doubleblind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus
-
Tabar AI, Echechipia S, Garcia BE, Olaguibel JM, Lizaso MT, Gomez B et al. Doubleblind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J Allergy Clin Immunol 2005;116:109-118.
-
(2005)
J Allergy Clin Immunol
, vol.116
, pp. 109-118
-
-
Tabar, A.I.1
Echechipia, S.2
Garcia, B.E.3
Olaguibel, J.M.4
Lizaso, M.T.5
Gomez, B.6
-
15
-
-
31744434189
-
Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts
-
Casanovas M, Martin R, Jimenez C, Caballero R, Fernández-Caldas E. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts. Int Arch Allergy Immunol 2006;139:153-158.
-
(2006)
Int Arch Allergy Immunol
, vol.139
, pp. 153-158
-
-
Casanovas, M.1
Martin, R.2
Jimenez, C.3
Caballero, R.4
Fernández-Caldas, E.5
-
16
-
-
44249114563
-
Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment
-
Subiza J, Feliú A, Subiza JL, Uhlig J, Fernández-Caldas E. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment. Clin Exp Allergy 2008;38:987-994.
-
(2008)
Clin Exp Allergy
, vol.38
, pp. 987-994
-
-
Subiza, J.1
Feliú, A.2
Subiza, J.L.3
Uhlig, J.4
Fernández-Caldas, E.5
-
17
-
-
63349083457
-
Safety of two Cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens
-
Pfaar O, Klimek L, Fischer I, Sieber J, Amoroso S, Moreno AC et al. Safety of two Cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens. Int Arch Allergy Immunol 2009;150:102-108.
-
(2009)
Int Arch Allergy Immunol
, vol.150
, pp. 102-108
-
-
Pfaar, O.1
Klimek, L.2
Fischer, I.3
Sieber, J.4
Amoroso, S.5
Moreno, A.C.6
-
18
-
-
53449090330
-
Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy
-
Schubert R, Eickmeier O, Garn H, Baer PC, Mueller T, Schulze J et al. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy. Int Arch Allergy Immunol 2009;148:251-260.
-
(2009)
Int Arch Allergy Immunol
, vol.148
, pp. 251-260
-
-
Schubert, R.1
Eickmeier, O.2
Garn, H.3
Baer, P.C.4
Mueller, T.5
Schulze, J.6
-
19
-
-
51849164024
-
Comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis
-
Zhang L, Wang C, Han D, Wang X, Zhao Y, Liu J. Comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis. Int Arch Allergy Immunol 2009;148:161-169.
-
(2009)
Int Arch Allergy Immunol
, vol.148
, pp. 161-169
-
-
Zhang, L.1
Wang, C.2
Han, D.3
Wang, X.4
Zhao, Y.5
Liu, J.6
-
20
-
-
73649084776
-
Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis
-
Pfaar O, Mösges R, Hörmann K, Klimek L. Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis. Eur Arch Otorhinolaryngol 2010;267:245-250.
-
(2010)
Eur Arch Otorhinolaryngol
, vol.267
, pp. 245-250
-
-
Pfaar, O.1
Mösges, R.2
Hörmann, K.3
Klimek, L.4
-
21
-
-
84855791137
-
A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy
-
Pfaar O, Urry Z, Robinson DS, Sager A, Richards D, Hawrylowicz CM et al. A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy. Allergy 2012;67:272-279.
-
(2012)
Allergy
, vol.67
, pp. 272-279
-
-
Pfaar, O.1
Urry, Z.2
Robinson, D.S.3
Sager, A.4
Richards, D.5
Hawrylowicz, C.M.6
-
23
-
-
84909591252
-
Ethical Principles for Medical Research Involving Human Subjects
-
World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the 59th WMA General Assembly, Edinburgh, Scotland, October 2000 and Washington 2002.
-
Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and Amended by the 59th WMA General Assembly, Edinburgh, Scotland, October 2000 and Washington 2002
-
-
World Medical Association Declaration of Helsinki1
-
25
-
-
33748539397
-
Standards for practical allergen-specific immunotherapy
-
Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E. Standards for practical allergen-specific immunotherapy. Allergy 2006;61(Suppl. 82):1-20.
-
(2006)
Allergy
, vol.61
, pp. 1-20
-
-
Alvarez-Cuesta, E.1
Bousquet, J.2
Canonica, G.W.3
Durham, S.R.4
Malling, H.J.5
Valovirta, E.6
-
26
-
-
33846964159
-
Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce
-
Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007;62:317-324.
-
(2007)
Allergy
, vol.62
, pp. 317-324
-
-
Canonica, G.W.1
Baena-Cagnani, C.E.2
Bousquet, J.3
Bousquet, P.J.4
Lockey, R.F.5
Malling, H.J.6
-
28
-
-
34547665695
-
Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials
-
Clark J, Shall R. Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials. Allergy 2007;62:1023-1028.
-
(2007)
Allergy
, vol.62
, pp. 1023-1028
-
-
Clark, J.1
Shall, R.2
-
29
-
-
77649313243
-
Klinische parameter zur Beurteilung der Wirksamkeit einer spezifischen Immuntherapie bei polleninduzierter Rhinitis allergica. Bestimmung von "well days" als ergänzendes Konzept
-
Vorwalder S, Pfaar O, Klimek L. Klinische parameter zur Beurteilung der Wirksamkeit einer spezifischen Immuntherapie bei polleninduzierter Rhinitis allergica. Bestimmung von "well days" als ergänzendes Konzept. Allergologie 2010;33:35-42.
-
(2010)
Allergologie
, vol.33
, pp. 35-42
-
-
Vorwalder, S.1
Pfaar, O.2
Klimek, L.3
-
30
-
-
36248986032
-
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis
-
Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120:1338-1345.
-
(2007)
J Allergy Clin Immunol
, vol.120
, pp. 1338-1345
-
-
Didier, A.1
Malling, H.J.2
Worm, M.3
Horak, F.4
Jäger, S.5
Montagut, A.6
-
31
-
-
0037358612
-
Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology
-
Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter WW et al. Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology. Laryngorhinootologie 2003;82:183-188.
-
(2003)
Laryngorhinootologie
, vol.82
, pp. 183-188
-
-
Riechelmann, H.1
Bachert, C.2
Goldschmidt, O.3
Hauswald, B.4
Klimek, L.5
Schlenter, W.W.6
-
32
-
-
0002457760
-
Immunotherapy. Position paper of the European Academy of Allergology and Clinical Immunotherapy
-
Malling HJ, Weeke B. Immunotherapy. Position paper of the European Academy of Allergology and Clinical Immunotherapy. Allergy 1993;48:7-35.
-
(1993)
Allergy
, vol.48
, pp. 7-35
-
-
Malling, H.J.1
Weeke, B.2
-
34
-
-
0025882782
-
Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate
-
Lehmacher W, Wassmer G, Reitmeir P. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate. Biometrics 1991;47:511-521.
-
(1991)
Biometrics
, vol.47
, pp. 511-521
-
-
Lehmacher, W.1
Wassmer, G.2
Reitmeir, P.3
-
35
-
-
68049134476
-
The problem of placebo-controlled trials allowing rescue medication: How to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment
-
Vent J, Lehmacher W. The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment. Curr Opin Allergy Clin Immunol 2009;9:222-227.
-
(2009)
Curr Opin Allergy Clin Immunol
, vol.9
, pp. 222-227
-
-
Vent, J.1
Lehmacher, W.2
-
37
-
-
84902083555
-
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: An EAACI Position Paper
-
Pfaar O, Demoly P, Gerth van Wijk R, Bonini S, Bousquet J, Canonica GW et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy 2014;69:854-867.
-
(2014)
Allergy
, vol.69
, pp. 854-867
-
-
Pfaar, O.1
Demoly, P.2
Gerth Van Wijk, R.3
Bonini, S.4
Bousquet, J.5
Canonica, G.W.6
-
38
-
-
0034995781
-
A well-tolerated grass pollenspecific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections
-
Drachenberg KJ, Wheeler AW, Stuebner P, Horak F. A well-tolerated grass pollenspecific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy 2001;56:498-505.
-
(2001)
Allergy
, vol.56
, pp. 498-505
-
-
Drachenberg, K.J.1
Wheeler, A.W.2
Stuebner, P.3
Horak, F.4
-
39
-
-
20044365298
-
Immunotherapy with depigmented glutaraldehyde-polymerized extracts: Changes in quality of life
-
Alvarez-Cuesta E, Aragoneses-Gilsanz E, Martín-Garcia C, Berges-Gimeno P, Gonzalez-Mancebo E, Cuesta-Herranz J. Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life. Clin Exp Allergy 2005;35:572-578.
-
(2005)
Clin Exp Allergy
, vol.35
, pp. 572-578
-
-
Alvarez-Cuesta, E.1
Aragoneses-Gilsanz, E.2
Martín-Garcia, C.3
Berges-Gimeno, P.4
Gonzalez-Mancebo, E.5
Cuesta-Herranz, J.6
-
40
-
-
20044371042
-
Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid
-
Corrigan CJ, Kettner J, Doemer C, Cromwell O, Narkus A. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 2005;60:801-807.
-
(2005)
Allergy
, vol.60
, pp. 801-807
-
-
Corrigan, C.J.1
Kettner, J.2
Doemer, C.3
Cromwell, O.4
Narkus, A.5
-
41
-
-
58149117614
-
Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy
-
Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009;123:167-173.
-
(2009)
J Allergy Clin Immunol
, vol.123
, pp. 167-173
-
-
Bufe, A.1
Eberle, P.2
Franke-Beckmann, E.3
Funck, J.4
Kimmig, M.5
Klimek, L.6
-
42
-
-
79955444722
-
Allergen-specific immunotherapy: Which outcome measures are useful in monitoring clinical trials?
-
Pfaar O, Kleine-Tebbe J, Hörmann K, Klimek L. Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials? Immunol Allergy Clin North Am 2011;31:289-309.
-
(2011)
Immunol Allergy Clin North Am
, vol.31
, pp. 289-309
-
-
Pfaar, O.1
Kleine-Tebbe, J.2
Hörmann, K.3
Klimek, L.4
-
43
-
-
84860786206
-
Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials
-
Calderon MA, Eichel A, Makatsori M, Pfaar O. Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials. Curr Opin Allergy Clin Immunol 2012;12:249-256.
-
(2012)
Curr Opin Allergy Clin Immunol
, vol.12
, pp. 249-256
-
-
Calderon, M.A.1
Eichel, A.2
Makatsori, M.3
Pfaar, O.4
-
44
-
-
34047163404
-
Mechanisms of allergen-specific immunotherapy
-
Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007;119:780-789.
-
(2007)
J Allergy Clin Immunol
, vol.119
, pp. 780-789
-
-
Akdis, M.1
Akdis, C.A.2
-
45
-
-
80051734103
-
Mechanisms of immunotherapy to aeroallergens
-
Shamji MH, Durham SR. Mechanisms of immunotherapy to aeroallergens. Clin Exp Allergy 2011;41:1235-1246.
-
(2011)
Clin Exp Allergy
, vol.41
, pp. 1235-1246
-
-
Shamji, M.H.1
Durham, S.R.2
-
46
-
-
79955441842
-
Serum immunologic markers for monitoring allergen-specific immunotherapy
-
Shamji MH, James LK, Durham SR. Serum immunologic markers for monitoring allergen-specific immunotherapy. Immunol Allergy Clin North Am 2011;31:311-323.
-
(2011)
Immunol Allergy Clin North Am
, vol.31
, pp. 311-323
-
-
Shamji, M.H.1
James, L.K.2
Durham, S.R.3
-
47
-
-
78349299047
-
Immunotherapy with depigmented-polymerized mixed tree pollen extract: A clinical trial and responder analysis
-
Pfaar O, Robinson DS, Sager A, Emuzyte R. Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis. Allergy 2010;65:1614-1621.
-
(2010)
Allergy
, vol.65
, pp. 1614-1621
-
-
Pfaar, O.1
Robinson, D.S.2
Sager, A.3
Emuzyte, R.4
|